{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T21:02:31Z","timestamp":1789246951524,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s10620-023-08143-5","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T09:02:51Z","timestamp":1697792571000},"page":"4407-4417","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Evaluating M2BPGi as a Marker for Liver Fibrosis in Patients with Chronic Hepatitis B"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2436-6712","authenticated-orcid":false,"given":"Hoang Huu","family":"Bui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suong Thi-Bang","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang The","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khue Minh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7703-0932","authenticated-orcid":false,"given":"Chuong Dinh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,20]]},"reference":[{"key":"8143_CR1","volume":"13","author":"M Zhu","year":"2022","unstructured":"Zhu M, Wang H, Lou T et al. Current treatment of chronic hepatitis B: Clinical aspects and future directions. Frontiers in microbiology. 2022;13:975584.","journal-title":"Frontiers in microbiology."},{"key":"8143_CR2","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","volume":"7","author":"GBD Hepatitis B Collaborators","year":"2022","unstructured":"GBD Hepatitis B Collaborators. Global, regional, and national burden of hepatitis B, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022;7:796\u2013829.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"8143_CR3","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault NA, Lok A, McMahon BJ et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67:1560\u20131599.","journal-title":"Hepatology."},{"key":"8143_CR4","first-page":"370","volume":"2017","author":"EASL. EASL","year":"2017","unstructured":"EASL. EASL. Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;2017:370\u2013398.","journal-title":"J Hepatol."},{"key":"8143_CR5","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","volume":"97","author":"A Regev","year":"2002","unstructured":"Regev A, Berho M, Jeffers LJ et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002;97:2614\u20132618.","journal-title":"Am J Gastroenterol."},{"key":"8143_CR6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","volume":"63","author":"EASL-ALEH Clinical Practice Guidelines","year":"2015","unstructured":"EASL-ALEH Clinical Practice Guidelines. Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63:237\u2013264.","journal-title":"J Hepatol."},{"key":"8143_CR7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cgh.2014.04.039","volume":"13","author":"EB Tapper","year":"2015","unstructured":"Tapper EB, Castera L, Afdhal NH. FibroScan (vibration-controlled transient elastography): where does it stand in the United States practice. Clin Gastroenterol Hepatol. 2015;13:27\u201336.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"8143_CR8","first-page":"659","volume":"2021","author":"EASL","year":"2021","unstructured":"EASL. Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update. J Hepatol. 2021;2021:659\u2013689.","journal-title":"J Hepatol."},{"key":"8143_CR9","volume-title":"Care and Treatment of Persons with Chronic Hepatitis B Infection","author":"Guidelines for the Prevention","year":"2015","unstructured":"Guidelines for the Prevention. Care and Treatment of Persons with Chronic Hepatitis B Infection. Geneva: World Health Organization; 2015."},{"key":"8143_CR10","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/srep01065","volume":"3","author":"A Kuno","year":"2013","unstructured":"Kuno A, Ikehara Y, Tanaka Y et al. A serum \u201csweet-doughnut\u201d protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis. Sci Rep. 2013;3:1065.","journal-title":"Sci Rep."},{"key":"8143_CR11","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1586\/14789450.2015.1084874","volume":"12","author":"H Narimatsu","year":"2015","unstructured":"Narimatsu H. Development of M2BPGi: a novel fibrosis serum glyco-biomarker for chronic hepatitis\/cirrhosis diagnostics. Expert Review of Proteomics. 2015;12:683\u2013693.","journal-title":"Expert Review of Proteomics."},{"key":"8143_CR12","first-page":"579","volume":"10","author":"Y Sumida","year":"2020","unstructured":"Sumida Y, Yoneda M, Seko Y et al. Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. Diagnostics (Basel, Switzerland). 2020;10:579.","journal-title":"Diagnostics (Basel, Switzerland)."},{"key":"8143_CR13","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/hep.27305","volume":"60","author":"K Yamasaki","year":"2014","unstructured":"Yamasaki K, Tateyama M, Abiru S et al. Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients. Hepatology. 2014;60:1563\u20131570.","journal-title":"Hepatology."},{"key":"8143_CR14","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s00535-014-1007-2","volume":"50","author":"M Abe","year":"2015","unstructured":"Abe M, Miyake T, Kuno A et al. Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease. J Gastroenterol. 2015;50:776\u2013784.","journal-title":"J Gastroenterol."},{"key":"8143_CR15","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ajg.2015.118","volume":"110","author":"T Umemura","year":"2015","unstructured":"Umemura T, Joshita S, Sekiguchi T et al. Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis. Am J Gastroenterol. 2015;110:857\u2013864.","journal-title":"Am J Gastroenterol."},{"key":"8143_CR16","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/hepr.12596","volume":"46","author":"H Nishikawa","year":"2016","unstructured":"Nishikawa H, Enomoto H, Iwata Y et al. Clinical significance of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level and high-sensitivity C-reactive protein concentration in autoimmune hepatitis. Hepatol Res. 2016;46:613\u2013621.","journal-title":"Hepatol Res."},{"key":"8143_CR17","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1111\/jgh.13802","volume":"32","author":"K Ito","year":"2017","unstructured":"Ito K, Murotani K, Nakade Y et al. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels and liver fibrosis: A meta-analysis. Journal of Gastroenterology and Hepatology 2017;32:1922\u20131930.","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"8143_CR18","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4254\/wjh.v12.i5.220","volume":"12","author":"TTT Pham","year":"2020","unstructured":"Pham TTT, Ho D, Nguyen T. Usefulness of Mac-2 binding protein glycosylation isomer in non-invasive probing liver disease in the Vietnamese population. World J Hepatol. 2020;12:220\u2013229.","journal-title":"World J Hepatol."},{"key":"8143_CR19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ajg.2017.469","volume":"113","author":"AK Singal","year":"2018","unstructured":"Singal AK, Bataller R, Ahn J et al. ACG Clinical Guideline: Alcoholic Liver Disease. Am J Gastroenterol. 2018;113:175\u2013194.","journal-title":"Am J Gastroenterol."},{"key":"8143_CR20","doi-asserted-by":"crossref","first-page":"099","DOI":"10.1093\/ofid\/ofz099","volume":"6","author":"SE Sansom","year":"2019","unstructured":"Sansom SE, Martin J, Adeyeami O et al. Steatosis rates by liver biopsy and transient elastography with controlled attenuation parameter in clinical experience of Hepatitis C Virus (HCV) and Human Immunodeficiency Virus\/HCV Coinfection in a Large US Hepatitis Clinic. Open Forum Infect Dis. 2019;6:099.","journal-title":"Open Forum Infect Dis."},{"key":"8143_CR21","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1553-2712.1996.tb03538.x","volume":"3","author":"NM Buderer","year":"1996","unstructured":"Buderer NM. Statistical methodology: I. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity. Acad Emerg Med. 1996;3:895\u2013900.","journal-title":"Acad Emerg Med."},{"key":"8143_CR22","doi-asserted-by":"crossref","first-page":"10582","DOI":"10.1038\/s41598-020-67471-y","volume":"10","author":"S Feng","year":"2020","unstructured":"Feng S, Wang Z, Zhao Y, Tao C. Wisteria floribunda agglutinin-positive Mac-2-binding protein as a diagnostic biomarker in liver cirrhosis: an updated meta-analysis. Sci Rep. 2020;10:10582.","journal-title":"Sci Rep."},{"key":"8143_CR23","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/hep.27382","volume":"61","author":"G Xiao","year":"2015","unstructured":"Xiao G, Yang J, Yan L. Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis. Hepatology. 2015;61:292\u2013302.","journal-title":"Hepatology."},{"key":"8143_CR24","doi-asserted-by":"crossref","unstructured":"European Association for Study of Liver Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63:237\u2013264.","DOI":"10.1016\/j.jhep.2015.04.006"},{"key":"8143_CR25","doi-asserted-by":"crossref","first-page":"124","DOI":"10.20892\/j.issn.2095-3941.2018.0018","volume":"15","author":"C Li","year":"2018","unstructured":"Li C, Li R, Zhang W. Progress in non-invasive detection of liver fibrosis. Cancer Biol Med. 2018;15:124\u2013136.","journal-title":"Cancer Biol Med."},{"key":"8143_CR26","first-page":"289","volume":"24","author":"P Bedossa","year":"1996","unstructured":"Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996;24:289\u2013293.","journal-title":"The METAVIR Cooperative Study Group. Hepatology."},{"key":"8143_CR27","unstructured":"The Ministry of Health of Vietnam. Guidelines for diagnosis and management of hepatitis B. 2019."},{"key":"8143_CR28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/1471-2334-14-405","volume":"14","author":"N Frulio","year":"2014","unstructured":"Frulio N, Trillaud H, Perez P et al. Acoustic Radiation Force Impulse (ARFI) and Transient Elastography (TE) for evaluation of liver fibrosis in HIV-HCV co-infected patients. BMC Infect Dis. 2014;14:405.","journal-title":"BMC Infect Dis."},{"key":"8143_CR29","first-page":"518","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai CT, Greenson J, Fontana RJ et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38:518\u2013526.","journal-title":"Hepatology."},{"key":"8143_CR30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","volume":"46","author":"A Vallet-Pichard","year":"2007","unstructured":"Vallet-Pichard A, Mallet V, Nalpas B et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology. 2007;46:32\u201336.","journal-title":"Hepatology."},{"key":"8143_CR31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41424-018-0020-9","volume":"9","author":"LY Mak","year":"2018","unstructured":"Mak LY, Wong DK, Cheung KS, Seto WK, Lai CL, Yuen MF. Role of serum M2BPGi levels on diagnosing significant liver fibrosis and cirrhosis in treated patients with chronic hepatitis B virus infection. Clinical and Translational Gastroenterology. 2018;9:163.","journal-title":"Clinical and Translational Gastroenterology."},{"key":"8143_CR32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32\u201335.","journal-title":"Cancer."},{"key":"8143_CR33","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.1038\/s41598-022-10744-5","volume":"12","author":"K Tangvoraphonkchai","year":"2022","unstructured":"Tangvoraphonkchai K, Suttichaimongkol T, Kularbkaew C, Sangaimwibool P, Sukeepaisarnjaroen W. Application of Mac-2 binding protein glycosylation isomer as a non-invasive biomarker for probing liver disease. Scientific Reports. 2022;12:6757.","journal-title":"Scientific Reports."},{"key":"8143_CR34","unstructured":"Cheng Y-M, Wang C-C. Comparison of Mac-2 binding protein glycosylation isomer (M2BPGi) with AST to platelet ratio index (APRI), fibrosis 4 Score (FIB-4), and nonalcoholic fatty liver disease (NAFLD) fibrosis score (NFS) for NAFLD patients.n\/a(n\/a)."},{"key":"8143_CR35","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.3748\/wjg.v26.i21.2864","volume":"26","author":"SA Saleh","year":"2020","unstructured":"Saleh SA, Salama MM, Alhusseini MM, Mohamed GA. M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals. World journal of gastroenterology. 2020;26:2864\u20132876.","journal-title":"World journal of gastroenterology."},{"key":"8143_CR36","doi-asserted-by":"crossref","first-page":"04076","DOI":"10.7189\/jogh.12.04076","volume":"12","author":"JP Vincent","year":"2022","unstructured":"Vincent JP, Ndow G, Ogawa S et al. Mac-2 binding protein glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa. Journal of global health. 2022;12:04076.","journal-title":"Journal of global health."},{"key":"8143_CR37","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1007\/s10620-022-07429-4","volume":"67","author":"LY Mak","year":"2022","unstructured":"Mak LY, Wong DK, Cheung KS et al. Role of Serum M2BPGi Levels in Predicting Persistence of Advanced Fibrosis in Chronic Hepatitis B Virus Infection. Digestive diseases and sciences. 2022;67:5127\u20135136.","journal-title":"Digestive diseases and sciences."},{"key":"8143_CR38","doi-asserted-by":"crossref","first-page":"14352","DOI":"10.1038\/s41598-017-14747-5","volume":"7","author":"J Liu","year":"2017","unstructured":"Liu J, Hu H-H, Lee M-H et al. Serum Levels of M2BPGi as Short-Term Predictors of Hepatocellular Carcinoma in Untreated Chronic Hepatitis B Patients. Scientific Reports. 2017;7:14352.","journal-title":"Scientific Reports."},{"key":"8143_CR39","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12876-017-0618-5","volume":"17","author":"H Xu","year":"2017","unstructured":"Xu H, Kong W, Liu L et al. Accuracy of M2BPGi, compared with Fibro Scan(R), in analysis of liver fibrosis in patients with hepatitis C. BMC Gastroenterol. 2017;17:62.","journal-title":"BMC Gastroenterol."},{"key":"8143_CR40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/liv.13188","volume":"37","author":"X Zou","year":"2017","unstructured":"Zou X, Zhou M, Yu DM et al. Serum WFA(+) -M2BP levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection. Liver Int. 2017;37:35\u201344.","journal-title":"Liver Int."},{"key":"8143_CR41","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/hepr.12703","volume":"47","author":"A Ishii","year":"2017","unstructured":"Ishii A, Nishikawa H, Enomoto H et al. Clinical implications of serum Wisteria floribunda agglutinin-positive Mac-2-binding protein in treatment-naive chronic hepatitis B. Hepatol Res. 2017;47:204\u2013215.","journal-title":"Hepatol Res."},{"key":"8143_CR42","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","volume":"128","author":"L Cast\u00e9ra","year":"2005","unstructured":"Cast\u00e9ra L, Vergniol J, Foucher J et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128:343\u2013350.","journal-title":"Gastroenterology."},{"key":"8143_CR43","first-page":"218","volume":"25","author":"V Papastergiou","year":"2012","unstructured":"Papastergiou V, Tsochatzis E, Burroughs AK. Non-invasive assessment of liver fibrosis. Ann Gastroenterol. 2012;25:218\u2013231.","journal-title":"Ann Gastroenterol."},{"key":"8143_CR44","doi-asserted-by":"crossref","first-page":"e22261","DOI":"10.1002\/jcla.22261","volume":"32","author":"B Wei","year":"2018","unstructured":"Wei B, Feng S, Chen E et al. M2BPGi as a potential diagnostic tool of cirrhosis in Chinese patients with Hepatitis B virus infection. J Clin Lab Anal. 2018;32:e22261.","journal-title":"J Clin Lab Anal."},{"key":"8143_CR45","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/apt.13488","volume":"43","author":"Y Li","year":"2016","unstructured":"Li Y, Huang YS, Wang ZZ et al. Systematic review with meta-analysis: the diagnostic accuracy of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B. Alimentary pharmacology & therapeutics. 2016;43:458\u2013469.","journal-title":"Alimentary pharmacology & therapeutics."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-08143-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-023-08143-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-08143-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T14:10:29Z","timestamp":1699539029000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-023-08143-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,20]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["8143"],"URL":"https:\/\/doi.org\/10.1007\/s10620-023-08143-5","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,20]]},"assertion":[{"value":"22 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare no conflict of interests for this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Patients signed informed consent regarding publishing their data and photographs.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"N\/A.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registration"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by University Medical Center Ho Chi Minh City (approval no.36\/GCN-H\u0110\u0110\u0110).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"N\/A.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Permission to reproduce material from other sources"}}]}}